Stockscreener 앱 받기
4.19
3.40%
-0.14
Atai Beckley N V 주식(ATAI)의 최신 뉴스
JonesTrading Initiates Coverage on ATAI Life Sciences With Buy Rating, $16 Price Target - marketscreener.com
Jones Trading initiates Buy rating on atai Life Sciences stock with $16 target - Investing.com
AtaiBeckley joins the Nasdaq Biotechnology Index - Proactive financial news
Atai Beckley Added to Nasdaq Biotechnology Index - marketscreener.com
Atai Beckley N.V. Added to NASDAQ Biotechnology Index, Marking a Significant Milestone for the Company - Quiver Quantitative
AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI) - The Manila Times
MarketBeat's Top 5 Rated Small-Cap Stocks - Finviz
Atai Beckley N.V.(NasdaqGM: ATAI) added to NASDAQ Biotechnology Index - marketscreener.com
Psychedelics stocks could benefit from marijuana rescheduling: Jefferies - MSN
How Does Atai (ATAI)’s New EMP-01 Patent Shape Its Psychedelic Therapy Moat? - simplywall.st
Atai Life Sciences N.V. (ATAI) Secures Patent for Social Anxiety Disorder Formulation - Insider Monkey
CapEx per share of Atai Beckley N.V – LSX:A3CSB4 - TradingView — Track All Markets
New EMP-01 Patent Win Could Be A Game Changer For Atai Beckley (ATAI) - simplywall.st
ATAI Beckley Secures US Patent for EMP-01 to Treat Social Anxiety Disorder; Shares Up Pre-Bell - marketscreener.com
AtaiBeckley Announces New U.S. Patent Granted for EMP-01, Strengthening Intellectual Property Portfolio - The Manila Times
AtaiBeckley (NASDAQ: ATAI) gains EMP-01 patent, eyes Phase 2a data in 2026 - Stock Titan
Atai Beckley files prospectus supplement for registered shares after Beckley Psytech acquisition - Investing.com Australia
Atai Beckley files prospectus supplement for registered shares after Beckley Psytech acquisition By Investing.com - Investing.com South Africa
ATAI Life Sciences Files Prospectus for Share Registration - TipRanks
Atai Beckley N.V. Files Prospectus Supplement for Common Shares - TradingView — Track All Markets
Atai Life Sciences (ATAI): Assessing an 8.8x Price-to-Book Valuation After a Volatile Share Price Run - Yahoo Finance
Atai Beckley (ATAI) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
ATAIAtai Beckley N.V Short Interest - Finviz
ATAI Life Sciences Files Prospectus for Share Resale - MSN
atai Life Sciences Reports Second Quarter 2025 Financial Results and Recent Corporate Updates - ADVFN
Form 8-KCurrent report - ADVFN
AtaiBeckley Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights - ADVFN
[Form 4] Atai Beckley N.V. Insider Trading Activity - Stock Titan
H.C. Wainwright Maintains Buy on Atai Beckley (ATAI) Following Breakthrough Therapy and Merger Completion - MSN
Atai Beckley N.V. (ATAI) latest stock news and headlines - Yahoo Finance UK
AtaiBeckley advances BPL-003 toward Phase 3 After Strong Phase 2 Data topline data i - Proactive financial news
9 Oversold Biotech Stocks to Invest In - Insider Monkey
Atai Beckley NV (NASDAQ:ATAI)Shares, Dividends & News - intelligentinvestor.com.au
Enhanced (ATAI) overhauls leadership, appoints new CEO, executive chairman and CFO - Stock Titan
Atai Beckley N.V. (ATAI) Receives Buy Rating on BPL-003 Edge against Spravato - MSN
Atai Beckley N.V (ATAI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
H.C. Wainwright reiterates Buy rating on atai Life Sciences stock By Investing.com - Investing.com Nigeria
H.C. Wainwright reiterates Buy rating on atai Life Sciences stock - Investing.com India
AtaiBeckley to Participate in the Jefferies Global Healthcare Conference in London - The Manila Times
AtaiBeckley (NASDAQ: ATAI) London fireside chat at 11:30 GMT; replay for 90 days - Stock Titan
AtaiBeckley advances clinical pipeline, strengthens balance sheet in Q3 - Proactive financial news
Atai Beckley Q3 Loss Widens, Revenue Rises; Shares Down Pre-Bell - MarketScreener
[8-K] ATAI Life Sciences N.V. Reports Material Event | ATAI SEC FilingForm 8-K - Stock Titan
Atai Beckley N.V. Announces Breakthrough Therapy Designation for BPL-003 and Positive Phase 2 Results for Treatment-Resistant Depression - Quiver Quantitative
Earnings Flash (ATAI) Atai Beckley N.V. Reports Q3 Revenue $749,000 - MarketScreener
Earnings Flash (ATAI) Atai Beckley Posts Q3 Net Loss $0.28 a Share, vs. FactSet Est of $0.11 Loss - MarketScreener
AtaiBeckley (NASDAQ: ATAI) closes approx. $150M offering, funding into 2029 - Stock Titan
0.63%
0.95%
자본화:
|
볼륨(24시간):